Minocycline Hydrochloride

Tetracycline Antibiotic Antibacterial

Dosage & Administration Guidelines

Species Route Dose Frequency Duration & Clinical Notes
Dog PO 5-12.5 mg/kg q12h Duration: 5-14 days depending on infection; for rickettsial infections, 14-21 days
Notes: Administer with food to reduce GI upset. For anti-inflammatory use, lower doses (e.g., 5 mg/kg q24h) may be used.
Cat PO 5-12.5 mg/kg q12h Duration: 5-14 days; for Mycoplasma haemofelis, 14-21 days
Notes: Cats are sensitive to tetracyclines; monitor for GI upset and fever. Use with caution in young animals.
Horse PO 4-10 mg/kg q12h Duration: 5-14 days
Notes: Oral absorption is variable; consider IV for severe infections. Not approved for horses in many countries.
Cattle PO 10-20 mg/kg q24h Duration: 3-5 days
Notes: Extra-label use; observe withdrawal times. Not commonly used; other tetracyclines preferred.
Sheep/Goat PO 10-20 mg/kg q24h Duration: 3-5 days
Notes: Extra-label use; observe withdrawal times.
Rabbit PO 5-10 mg/kg q12h Duration: 5-7 days
Notes: Use with extreme caution due to risk of enterotoxemia; monitor fecal output.
Bird (pet) PO 25-50 mg/kg q12h Duration: 5-14 days
Notes: May be used for chlamydiosis; ensure adequate hydration.

Clinical Indications & Species Uses

General Indications
  • Infections caused by susceptible gram-positive and gram-negative bacteria, Mycoplasma, Chlamydia, Rickettsia, and some anaerobes.
  • Anti-inflammatory and immunomodulatory therapy for non-infectious conditions (e.g., immune-mediated polyarthritis, dermatological conditions) in dogs and cats.
Dog (Canine)
  • Treatment of infections caused by susceptible strains of Staphylococcus spp., Streptococcus spp., Pasteurella spp., and Mycoplasma spp.
  • Canine acne and superficial pyoderma (as an alternative to other antibiotics)
  • Periodontal disease (adjunctive therapy)
  • Rickettsial infections (e.g., Ehrlichia canis, Anaplasma phagocytophilum, Rickettsia rickettsii)
  • Borreliosis (Lyme disease) as an alternative to doxycycline
  • Mycoplasma infections (e.g., Mycoplasma haemocanis)
Cat (Feline)
  • Upper respiratory tract infections caused by Bordetella bronchiseptica, Chlamydia felis, and Mycoplasma spp.
  • Hemotropic mycoplasmosis (Mycoplasma haemofelis)
  • Rickettsial infections (e.g., Ehrlichia, Anaplasma)
  • Dermatological infections (e.g., pyoderma, abscesses) when susceptible
  • Feline acne
Horse (Equine)
  • Respiratory tract infections caused by susceptible organisms (e.g., Rhodococcus equi, but not first-line)
  • Skin and soft tissue infections
  • Lyme disease (Borrelia burgdorferi) as an alternative to doxycycline
  • Mycoplasma infections
Cattle (Bovine)
  • Anaplasmosis (Anaplasma marginale) in some regions, but oxytetracycline is more common.
Exotic & Other Species
  • Reptiles: Mycoplasma infections (e.g., Mycoplasma agassizii in tortoises)
  • Small mammals (e.g., ferrets): Respiratory infections, but use with caution.

Pharmacology & Mechanism of Action

Drug Class: Tetracycline Antibiotic | Pharmacological Group: Antibacterial

Mechanism of Action: Minocycline is a semi-synthetic tetracycline that inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit, preventing the attachment of aminoacyl-tRNA to the mRNA-ribosome complex. This action is bacteriostatic and affects susceptible gram-positive and gram-negative bacteria, as well as certain atypical organisms such as Mycoplasma, Chlamydia, and Rickettsia. It also has anti-inflammatory and immunomodulatory properties, including inhibition of matrix metalloproteinases and downregulation of pro-inflammatory cytokines, which may contribute to its efficacy in non-infectious inflammatory conditions.

Pharmacodynamics: Minocycline exhibits time-dependent antibacterial activity with a post-antibiotic effect. It is more lipophilic than other tetracyclines, leading to enhanced tissue penetration, particularly into the central nervous system, prostate, and skin. Its anti-inflammatory effects are observed at sub-antimicrobial doses, making it useful in dermatological and periodontal diseases. In veterinary species, its spectrum includes Staphylococcus spp., Streptococcus spp., Pasteurella spp., Bordetella bronchiseptica, Mycoplasma spp., and Chlamydia spp. Resistance can occur via efflux pumps or ribosomal protection proteins.

⚡ Pharmacokinetics Summary

Absorption: Minocycline is well absorbed after oral administration in most species, with bioavailability exceeding 90% in dogs and cats. Absorption is minimally affected by food, but concurrent administration with dairy products or antacids containing divalent cations (calcium, magnesium, aluminum) can chelate and reduce absorption.
Distribution: Minocycline is widely distributed throughout the body, with high concentrations in tissues and fluids, including the skin, saliva, tears, bronchial secretions, and prostate. It crosses the blood-brain barrier more effectively than other tetracyclines, achieving therapeutic levels in the CNS. It crosses the placenta and is excreted in milk.
Metabolism: Minocycline undergoes partial hepatic metabolism to several metabolites, including 11-alpha-hydroxy-minocycline and 9-hydroxy-minocycline. The extent of metabolism varies among species; in dogs, metabolism is significant, while in cats, it is less extensive.
Excretion: Excretion occurs primarily via the biliary route into the feces, with a smaller amount excreted renally. Unlike other tetracyclines, minocycline does not accumulate significantly in renal failure, but dose adjustment may still be necessary in severe hepatic or renal impairment.
Half-Life: Dogs: approximately 6-8 hours; Cats: approximately 8-12 hours; Horses: approximately 4-6 hours; Cattle: approximately 5-7 hours.
Bioavailability: Oral bioavailability is high (90-100%) in dogs and cats; in horses, it is approximately 60-70%.
Protein Binding: Minocycline is approximately 75-80% protein-bound in dogs and cats.

Available Formulations & Strengths

Oral Tablet 50 mg, 75 mg, 100 mg (PO)
Oral Capsule 50 mg, 100 mg (PO)
Oral Suspension 50 mg/5 mL (PO)
Injectable Solution (IV) 100 mg/5 mL (20 mg/mL) (IV)

Contraindications & Clinical Warnings

Contraindications:
  • Hypersensitivity to minocycline or other tetracyclines
  • Severe hepatic impairment
  • Pregnancy (especially in the last half of gestation) due to effects on fetal bone and teeth development
  • Lactating animals (unless benefit outweighs risk, as it is excreted in milk)
  • Young animals (under 6 months of age in dogs, under 12 weeks in cats) due to potential teeth discoloration and bone growth retardation
  • Concurrent use with systemic retinoids (e.g., isotretinoin) due to increased risk of pseudotumor cerebri
Warnings & Clinical Precautions:
  • Use with caution in animals with renal or hepatic disease; dose adjustment may be necessary.
  • May cause gastrointestinal upset; administer with food.
  • In horses, oral administration may cause diarrhea and colitis; monitor closely.
  • In ruminants, oral administration may disrupt rumen flora; use with caution.
  • Photosensitivity reactions may occur; avoid excessive sunlight exposure during treatment.
  • Prolonged use may result in overgrowth of non-susceptible organisms, including Candida and Clostridioides difficile.
  • In cats, tetracyclines can cause fever, depression, and anorexia; discontinue if these occur.
  • Do not use in animals with myasthenia gravis due to potential neuromuscular blockade.
  • Use with caution in animals receiving anticoagulants; may enhance their effect.

Adverse Effects & Reactions

Common:

  • Gastrointestinal upset (vomiting, diarrhea, anorexia)
  • Esophageal irritation or stricture (especially in cats if tablets are not followed by water)
  • Tooth discoloration and enamel hypoplasia in young animals
  • Photosensitivity
  • Injection site reactions (if IV)

Serious / Severe:

  • Hepatotoxicity (rare but possible)
  • Nephrotoxicity (especially with outdated tetracyclines, but minocycline is less nephrotoxic)
  • Vestibular toxicity (dizziness, ataxia) in dogs and cats
  • Pseudotumor cerebri (increased intracranial pressure) with prolonged use
  • Blood dyscrasias (neutropenia, thrombocytopenia) - rare
  • Anaphylaxis (rare)

Rare:

  • Systemic lupus erythematosus-like syndrome
  • Drug-induced autoimmune hepatitis
  • Stevens-Johnson syndrome
  • Exfoliative dermatitis
  • Peripheral neuropathy

Key Drug Interactions

Interacting Drug / Class Clinical Effect & Mechanism Severity
Antacids (aluminum, calcium, magnesium) Reduced absorption of minocycline due to chelation; separate administration by at least 2 hours. Moderate
Iron supplements, bismuth subsalicylate, sucralfate Reduced absorption of minocycline; separate administration by at least 2 hours. Moderate
Oral contraceptives (in humans; not typically used in animals) May reduce efficacy of oral contraceptives; not relevant in veterinary medicine. Mild
Warfarin and other anticoagulants Minocycline may enhance the anticoagulant effect; monitor prothrombin time. Moderate
Penicillins (e.g., amoxicillin) Bacteriostatic drugs may antagonize bactericidal effects of penicillins; avoid concurrent use. Moderate
Isotretinoin or other retinoids Increased risk of pseudotumor cerebri; avoid concurrent use. High
Methoxyflurane (anesthetic) Potential for nephrotoxicity; avoid concurrent use. High

Overdose & Toxicity Management

Signs of Toxicity:

  • Gastrointestinal signs (vomiting, diarrhea, anorexia)
  • Ataxia and dizziness (vestibular signs)
  • Hepatotoxicity (elevated liver enzymes, jaundice)
  • Renal toxicity (increased BUN/creatinine)
  • Metabolic acidosis (rare)
  • Photosensitivity

Emergency Treatment Protocol: Treatment is primarily symptomatic and supportive. Induce emesis if ingestion is recent (within 1-2 hours) and the animal is conscious. Administer activated charcoal to reduce absorption. Provide intravenous fluids to maintain hydration and support renal function. Monitor liver and kidney function. For severe vestibular signs, provide supportive care and consider antiemetics. There is no specific antidote. In cases of severe overdose, consider hemodialysis (though minocycline is highly protein-bound, so efficacy is limited).

Food Animal Withdrawal Times

🥩 Meat: 4 days🥛 Milk: 3 days

Withdrawal times are not established for minocycline in food animals; these are extrapolated from tetracycline class. For extra-label use, consult FARAD (Food Animal Residue Avoidance Databank) for specific guidance. In cattle, a meat withdrawal of 4 days and milk withdrawal of 3 days are commonly recommended, but must be verified.

Storage, Handling & Regulatory Information

Storage Temperature: Store at controlled room temperature 20-25°C (68-77°F), with excursions permitted between 15-30°C (59-86°F).

Light Sensitivity: Light-sensitive — protect from direct exposure.

Handling & Special Conditions: Protect from light, moisture, and excessive heat. Keep in a tightly closed container. Do not use if discolored or if precipitate forms in the oral suspension.

Dispensing Status: Prescription Required (Rx Only)

Approval Status: Not FDA-approved for veterinary use; approved for human use. Veterinary use is extra-label.

Extra-Label (Off-Label) Use: In the US, minocycline is not FDA-approved for veterinary species; use in animals is extra-label. Under AMDUCA, extra-label use is permitted by or on the order of a licensed veterinarian within a valid VCPR, provided that withdrawal times are extended and residues do not exceed tolerance levels. In food animals, extra-label use is prohibited if an approved drug is available that is labeled for the indication and species.

Clinical Pearls & Practice Notes

💡 Clinical Insights: Minocycline is a valuable antibiotic in veterinary medicine, particularly for infections caused by intracellular pathogens such as Rickettsia, Mycoplasma, and Chlamydia. Its high lipophilicity allows excellent tissue penetration, including the CNS and skin. It is often used as an alternative to doxycycline, especially when CNS involvement is suspected. However, its use is limited by cost and the availability of other tetracyclines. In dogs and cats, it is generally well-tolerated, but gastrointestinal upset is common. In horses, oral administration may be associated with diarrhea and colitis, so it should be used with caution. For food animals, extra-label use is possible but withdrawal times must be observed. Anti-inflammatory doses are lower than antimicrobial doses and may be used for conditions like immune-mediated polyarthritis or dermatological diseases. Always perform culture and sensitivity testing when possible to ensure susceptibility. Monitor for adverse effects, especially in young animals and those with hepatic or renal impairment.

References & Literature

  • 📚 Plumb's Veterinary Drug Handbook
  • 📚 Papich Veterinary Pharmacology and Therapeutics
  • 📚 Compendium of Veterinary Products (CVP)